My HPRA: Register

EXELON

13.3 mg/24 hours Transdermal Patch

Novartis Europharm LimitedEU/1/98/066/027-030

Main Information

Trade NameEXELON
Active SubstancesRIVASTIGMINE
Strength13.3 mg/24 hours
Dosage FormTransdermal Patch
Licence HolderNovartis Europharm Limited
Licence NumberEU/1/98/066/027-030

Group Information

ATC CodeN06DA03 Anticholinesterases

Status

Authorised/WithdrawnAuthorised
Licence Issued14/03/2013
Supply StatusSupply through pharmacies only
Dispensing StatusProduct subject to prescription which may not be renewed (A)
Marketing Status--Unknown--
Promotion StatusPromotion to Healthcare Professionals only
Conditions of Licence

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website

Educational Materials - Patient

Patient Diary
« Back
Follow medicine

Print